mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.3 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.3 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.3 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.4 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |